Xu L, Xue B, Zhou L, Qiu Z, Zhang X, Xu N, Tang Q, Zhu J, Guan X, Feng Z
Department of Pathology, Nanjing Medical University, Nanjing, China.
The Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing, China.
Parasite Immunol. 2018 May;40(5):e12528. doi: 10.1111/pim.12528.
The murine monoclonal anti-idiotypic antibody, NP30, is a potential vaccine candidate against Schistosoma japonicum. Previous studies have revealed that NP30 has an immunoregulatory effect, but the underlying mechanism for this effect remains unknown. This study shows that NP30 induces dendritic cell (DC) maturation and increases the production of pro-inflammatory cytokines. The expression of CD86 and MHC II was upregulated in DCs following stimulation with NP30 in vitro. Moreover, NP30 induced Th17 polarization by increasing the production of IL-6 and TGF-β. In vivo, Th17 differentiation was induced by the production of key pro-inflammatory cytokines, including IL-6and TGF-β, from DCs of NP30-immunized mice. These results indicate that NP30 promotes Th17 polarization through DC activation, preventing serious schistosomiasis.
鼠源单克隆抗独特型抗体NP30是一种潜在的抗日本血吸虫疫苗候选物。先前的研究表明NP30具有免疫调节作用,但其作用的潜在机制仍不清楚。本研究表明,NP30可诱导树突状细胞(DC)成熟并增加促炎细胞因子的产生。体外经NP30刺激后,DC中CD86和MHC II的表达上调。此外,NP30通过增加IL-6和TGF-β的产生诱导Th17极化。在体内,NP30免疫小鼠的DC产生包括IL-6和TGF-β在内的关键促炎细胞因子,从而诱导Th17分化。这些结果表明,NP30通过DC激活促进Th17极化,预防严重血吸虫病。